AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25586724
Drug: sugammadex 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex 1.0 mg kg(‐1)
Trial: 22751847
Drug: Fingolimod, 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod, 1.25 mg
Trial: 22354739
Drug: Fingolimod (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod (both doses)
Trial: 21375019
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for 30 min, once daily for 4 weeks.
Trial: 21375019
Drug: Mecobalamine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecobalamine (500 microg) intramuscular injection, once daily for 4 weeks.
Trial: 21375019
Drug: Mecobalamine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecobalamine treatment
Trial: 17699944
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone 200 mg once daily for three days
Trial: 17699944
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone 250 mg/six-hourly for three days followed by oral prednisolone for 11 days
Trial: 16045572
Drug: High-dose-rate endoluminal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose-rate endoluminal brachytherapy (7 Gy x 3 given in 2-4 weeks)
Trial: 10429771
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dolasetron orally 45‐60 minutes before anaesthesia
Trial: 10429771
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg i.v. DHB + placebo p.o. (positive control group)
Trial: 10429771
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dolasetron orally 45‐60 minutes before anaesthesia and 2.5 mg i.v. DHB during anaesthesia
Trial: 10429771
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet administered 45‐60 minutes before anaesthesia (negative control group)
Trial: 8680536
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg twice daily for 6 weeks
Trial: 8680536
Drug: Double-therapy (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-therapy (300 mg amoxicillin granules and 250 mg metronidazole thrice daily for 2 weeks + cimetidine)
Trial: 6432001
Drug: Niludipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niludipine (20 mg)
Trial: 6432001
Drug: Nifedipine (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (chronic administration)
Trial: 6432001
Drug: Niludipine (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niludipine (chronic administration)
Trial: 30885134
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg bolus followed by 1.5 mg/kg/h infusion)
Trial: 30885134
Drug: Intravenous dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexmedetomidine (0.5 μg/kg bolus followed by 0.4 μg/kg/h infusion)
Trial: 24477319
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of parathyroid hormone (PTH) for 6 weeks
Trial: 24477319
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment (standard care)
Trial: 19123156
Drug: Oral supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplementation with EPA (720 mg/day) and DHA (480 mg/day) for 6 months
Trial: 17242426
Drug: Atomoxetine (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (1.2 mg/kg daily for 3 weeks)
Trial: 15970715
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose heparin (600 U/kg)
Trial: 15970715
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin (300 U/kg)
Trial: 7895538
Drug: Pure fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure fat meal (25 g triglycerides)
Trial: 7895538
Drug: Mixed meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed meal (8 g fat, 10 g protein, 32 g dextrose)
Trial: 7895538
Drug: Fat-free meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat-free meal (25 g albumin, 32 g dextrose)
Trial: 2403903
Drug: Iodinated glycerol
RxNorm normalized name: iodinated glycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodinated glycerol (Organidin), 60 mg qid
Trial: 79028
Drug: Intravenous cholangiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cholangiography (I.V.C.)
Trial: 27515478
Drug: pPDT (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pPDT (placebo photodynamic therapy)
Trial: 26077585
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents with thrombus aspiration
Trial: 16563810
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment with additional brace treatment
Trial: 16563810
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment alone
Trial: 15283826
Drug: Dexamethasone (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (50, 100, 150 microg x kg(‐1), maximum dose 8 mg) with ondansetron (50 microg x kg(‐1))
Trial: 11739137
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 200 microg/d (constant dose approach)
Trial: 8424427
Drug: Lymphoblastoid alpha-interferon
RxNorm normalized name: interferon alfa-n1 lymphoblastoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphoblastoid alpha-interferon (L-IFN)
Trial: 28735368
Drug: Ketanserin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (40 mg) as pre-treatment
Trial: 25436319
Drug: Combined Therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Therapy (HAIC plus systemic chemotherapy)
Trial: 25436319
Drug: Monotherapy (systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (systemic chemotherapy alone)
Trial: 21086017
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide therapy for 4 years
Trial: 20380708
Drug: Activ-L Artificial
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activ-L Artificial Disc
Trial: 20380708
Drug: Charité Artificial
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Charité Artificial Disc [DePuy Spine] or ProDisc-L Total Disc Replacement [Synthes Spine]
Trial: 16105333
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg intramuscularly (i.m.) 30 min before the procedure
Trial: 16105333
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg i.m. 30 min before the procedure, together with local infiltration of the cervix with lignocaine 1% (10 mL)
Trial: 16105333
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg i.m. 30 min before the procedure together with local infiltration of the cervix with lignocaine 1% (10 mL) and paracervical block with lignocaine 1% (5 mL)
Trial: 11788216
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (1-mg nicotine)
Trial: 11788216
Drug: Cigarette smoke
RxNorm normalized name: cigarette smoke
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoke (1-mg nicotine, 12 mg tar)
Trial: 10037314
Drug: Gabexate mesilate
RxNorm normalized name: mesylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabexate mesilate (GM) administered continuously at 1.5 mg/kg per hour from the beginning of anesthesia until the third postoperative day (preop GM group)
Trial: 10037314
Drug: Gabexate mesilate
RxNorm normalized name: mesylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabexate mesilate (GM) administered continuously at 1.5 mg/kg per hour from the end of surgery and for the same postoperative period (postop GM group)
Trial: 10037314
Drug: Gabexate mesilate
RxNorm normalized name: mesylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabexate mesilate (GM) administered in the preop GM group
Trial: 2309827
Drug: Continuous ethinyl
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous ethinyl estradiol and norethindrone acetate (various doses)
Trial: 2309827
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens 0.625 mg and medroxyprogesterone acetate 10 mg
Trial: 48835
Drug: Propranolol and
RxNorm normalized name: propranolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol and insulin
Trial: 25213161
Drug: Regorafenib 160
RxNorm normalized name: Regorafenib
DrugBank: Regorafenib (DB08896)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Regorafenib 160 mg once daily for weeks 1-3 of each 4-week cycle
Trial: 24187864
Drug: BHY group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BHY group (BHY instant granules, 6 g, twice per day)
Trial: 24187864
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (piracetam, 0.8 g, 3 times per day)
Trial: 16420200
Drug: Simvastatin up
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin up to 20 mg/d for 15 weeks
Trial: 7698862
Drug: Bioabsorbable osteosynthetic
RxNorm normalized name: COLLAGEN HEMOSTAT,ABSORBABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioabsorbable osteosynthetic implants of ultra high strength poly-L-lactide (PLLA)
Trial: 3556192
Drug: Buccal nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal nifedipine 20 mg
Trial: 27110823
Drug: Synthetic unimolecular
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic unimolecular pentavalent carbohydrate vaccine (Globo‐H, GM2, sTn, TF, and Tn) conjugated to keyhole limpet haemocyanin (KLH) mixed with immunological adjuvant QS‐21 at doses of 25, 50, and 100 mcg.
Trial: 23687780
Drug: Nurse-led case
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-led case management program (monthly telephone calls, motivational interviewing for lifestyle change, home BP monitoring, dosettes for medication administration)
Trial: 16423519
Drug: St. John's
RxNorm normalized name: St. john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St. John's Wort (PM235) - lower dose (0.12% hypericine)
Trial: 16423519
Drug: St. John's
RxNorm normalized name: St. john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St. John's Wort (PM235) - higher dose (0.18% hypericine)
Trial: 16423519
Drug: St. John's
RxNorm normalized name: St. john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St. John's Wort (PM235) - pooled high and low doses
Trial: 11727665
Drug: GTN patches
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTN patches (0.4‐0.8 mg/h)
Trial: 9228496
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal estradiol (0.050 mg/day)
Trial: 9228496
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral conjugated estrogens (0.625 mg/day)
Trial: 30658096
Drug: rIPC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIPC treatment (n=8)
Trial: 23988179
Drug: Pharmacotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy plus cognitive-coping therapy (PCCT)
Trial: 20607405
Drug: Pantoprazole high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole high dose (1.2 mg/kg)
Trial: 20607405
Drug: Pantoprazole low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole low dose (0.6 mg/kg)
Trial: 3125025
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg and misoprostol 400 micrograms bid
Trial: 29494423
Drug: Genotype-guided pharmacogenetics
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotype-guided pharmacogenetics guided (PHG) warfarin dosing
Trial: 29494423
Drug: Clinically guided
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically guided non pharmacogenetics guided (NPHG) warfarin dosing
Trial: 27016718
Drug: Ablative fractional
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ablative fractional Er:YAG laser at 11.2 mJ per laser channel with 1% density, MAL 160 mg/g, 180 min incubation
Trial: 27016718
Drug: MAL 80
RxNorm normalized name: maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAL 80 and 160 mg/g
Trial: 23852294
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral treatment (HAART)
Trial: 20186439
Drug: Lidocaine 1
RxNorm normalized name: lidocaine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1 mg kg(‐1)
Trial: 20186439
Drug: Lidocaine 1
RxNorm normalized name: lidocaine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1 mg kg(‐1) with remifentanil 1 microg kg(‐1) min(‐1)
Trial: 20186439
Drug: Rocuronium 1
RxNorm normalized name: rocuronium 10 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 1 mg kg(‐1)
Trial: 20186439
Drug: Propofol 2‐2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2‐2.5 mg kg(‐1)
Trial: 18243569
Drug: Probiotic drink
RxNorm normalized name: CVS Probiotic Drink Mix 10 Billion CFU Powder for Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic drink containing Lactobacillus casei DN‐114 001 at 10(8) CFU/g
Trial: 15891924
Drug: Midazolam (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.6 mg/kg)
Trial: 15891924
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate (25 mg/kg)
Trial: 1518258
Drug: Mean relative
RxNorm normalized name: (2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean relative dose greater than 0.9
Trial: 30176897
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose primaquine (0.5 mg base/kg body weight) for 14 days
Trial: 30176897
Drug: Conventional dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose primaquine (0.25 mg/kg) for 14 days
Trial: 27629871
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 2 g daily
Trial: 18580611
Drug: Four injections
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four injections of ALVAC-HIV vaccine (vCP1452) at weeks 0, 4, 8, 20
Trial: 18580611
Drug: Three injections
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three injections of ALVAC-HIV vaccine (vCP1452) at weeks 4, 8, 20
Trial: 18580611
Drug: Four injections
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four injections of ALVAC-HIV vaccine (vCP1452)
Trial: 18580611
Drug: Three injections
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three injections of ALVAC-HIV vaccine (vCP1452)
Trial: 18580611
Drug: Immunization (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunization (both three and four injections)
Trial: 10778521
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg + nimesulide 100 mg
Trial: 9345406
Drug: High-dose Betaseron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Betaseron
Trial: 9345406
Drug: Low-dose Betaseron
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Betaseron
Trial: 1828683
Drug: Picotamide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide (300 mg x 3 daily)
Trial: 31776820
Drug: Intraoperative iodine
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative iodine (5 mL of 0.25% povidone-iodine applied at 2 stages)
Trial: 31776820
Drug: Preoperative topical
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative topical antibiotics (administered 3 days before surgery)
Trial: 31898677
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch (30 gm daily)
Trial: 30335422
Drug: Prolonged exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged exposure therapy for PTSD
Trial: 30335422
Drug: Cognitive and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive and behavioral therapies for OCD
Trial: 30335422
Drug: Psychodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychodynamic therapy in a naturalistic setting
Trial: 25825091
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine (CHX) mouth rinse used twice daily for one week
Trial: 17937843
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (10 mg/kg first dose, followed by two doses of 5 mg/kg each at 24 hr intervals)
Trial: 17937843
Drug: Oral indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral indomethacin (0.2 mg/kg at 24 hr intervals)
Trial: 15200437
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of iron (III) sucrose
Trial: 15200437
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of iron (III) sucrose
Trial: 8796137
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fenfluramine
Trial: 8796137
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg fenfluramine
Trial: 8796137
Drug: CRH injection
RxNorm normalized name: Ovine CRH
DrugBank: Corticorelin ovine triflutate (DB09067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRH injection
Trial: 1620826
Drug: rTPA plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTPA plus heparin
Trial: 1620826
Drug: rTPA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTPA with or without heparin
Trial: 6538427
Drug: Cimetidine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1000 mg) with phenazone (15 mg/kg)
Trial: 6538427
Drug: Metronidazole (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (1000 mg) with phenazone (15 mg/kg)
Trial: 30853816
Drug: Extended venous
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended venous thromboembolism prophylaxis (vte) with low molecular weight heparin (lmwh)
Trial: 27322798
Drug: Pioglitazone, 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone, 45 mg/d
Trial: 22137494
Drug: Estriol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol (2 mg/day for 8 weeks)
Trial: 17906762
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil capsules 1 g/day
Trial: 17906762
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil capsules 2 g/day